IRCT20170123032145N5尚未招募2 期
Agomelatine as Adjunctive Therapy in Obsessive Compulsive Disorder A Double-blind,Placebo-controlled,Randomized Trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Patients who meet DSM-5 criterion for OCD
- •Achieve more than 21 for Yale-Brown Obsessive Compulsive Scale
- •Age: 18-65 year old
- •Sign consent form
排除标准
- •They should not be treated by any psychiatric intervention for last 6 weeks.
- •If they show any other important mental condition or suicidal thought, neurological deficit, will exclude from study.
- •They will be evaluated for cardiac, liver, kidney, pregnancy, lactation and mental retardation before entrance and any mentioned conditions will cause exclusion from study.
研究者
相似试验
已完成
3 期
Evaluation of the Efficacy of Agomelatine as Add-on Therapy on the Aggression, Agitation, and its Relationship with Serum Brain-Derived Neurotrophic Factor (BDNF) of Patients with Alzheimer’s disease DementiaBehavioral and Psychological Symptoms of Dementia.Alzheimer's diseaseIRCT20170608034390N10Shahid Beheshti University of Medical Sciences56
已完成
2 期
Efficacy of Agomelatine in Patients With Obsessive-Compulsive DisorderObsessive Compulsive DisorderNCT01108393Institut de Recherches Internationales Servier74
已完成
不适用
AC add on to the treatment of refractory obssessive compulsive disorder: A double-blind clinical trialObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT138806101743N2Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences72
进行中（未招募）
1 期
Efficacy and safety of Agomelatine (25 mg with potential adjustment at 50 mg) given orally once a day for 12 weeks in out-patients with Generalised Anxiety Disorder. A randomised flexible dose double-blind, placebo-controlled, parallel groups, international study.Generalised Anxiety DisorderMedDRA version: 3.3Level: P.T.Classification code 10018075EUCTR2004-002577-23-FIInstitut de Recherches Internationales Servier120
已完成
3 期
Glutamatergic medication in the treatment of Obsessive Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD)Obsessief Compulsieve StoornisAutism Spectrum Disorder and Obsessive Compulsive Disorder10010118NL-OMON41943Radboudumc, Donders Institute of Brain, Cognition and Behavior48